Sucampo Pharmaceuticals, Inc.

CIK 1365216 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Sucampo Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Feb 23, 201815-12B0001193125-18-054970
Feb 15, 2018SC 13D/A0001193125-18-047292
Feb 15, 2018EFFECT9999999995-18-000448
Feb 15, 2018EFFECT9999999995-18-000454
Feb 15, 2018EFFECT9999999995-18-000450
Feb 15, 2018EFFECT9999999995-18-000455
Feb 15, 2018SC 13D/A0001193125-18-047291
Feb 14, 201840000899243-18-003897
Feb 14, 201840000899243-18-003892
Feb 13, 2018SC 13G/A0001140361-18-007085
Feb 13, 201840001171843-18-001099
Feb 13, 2018SC 13G0001050470-18-000044
Feb 13, 2018POS AM0001193125-18-041632
Feb 13, 201840001171843-18-001108
Feb 13, 201840001171843-18-001101
Feb 13, 201840001171843-18-001109
Feb 13, 2018POS AM0001193125-18-041640
Feb 13, 201840001171843-18-001111
Feb 13, 201840001171843-18-001112
Feb 13, 2018POS AM0001193125-18-041617
Feb 13, 20188-K0001193125-18-041486
Feb 13, 201840001171843-18-001103
Feb 13, 201840001171843-18-001110
Feb 13, 2018SC 14D9/A0001193125-18-041459
Feb 13, 201840001171843-18-001107